LEHI, Utah, June 25, 2025 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (NASDAQ: NATR) (“Nature’s Sunshine” or the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the launch of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the “Selling Stockholder”). The Selling Stockholder will receive all of the net proceeds from the offering. Nature’s Sunshine is not selling any sha ...

SAN FRANCISCO, June 25, 2025 /PRNewswire/ -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.Prom ...

Core Viewpoint - FedEx Corporation's shares fell 5.96% in after-market trading due to concerns over volatile global demand and uncertainty regarding U.S. trade policies, particularly with China, despite reporting strong fourth-quarter fiscal 2025 results [1][9]. Financial Performance - FedEx's quarterly earnings of $6.07 per share exceeded the Zacks Consensus Estimate of $5.93, marking a 12.2% year-over-year improvement [2]. - Revenues reached $22.2 billion, surpassing the Zacks Consensus Estimate of $21.7 billion and reflecting a 0.5% increase from the previous year [2]. - Operating income increased by 15% to $1.79 billion, with operating margin rising to 8.1% from 7% year-over-year [3]. Cost Management - The quarterly results benefited from cost reductions due to the DRIVE program, increased volume at Federal Express, and higher base yield across transportation segments [3]. - Operating expenses decreased by 1% to $20.4 billion [4]. Segment Performance - FedEx Express segment revenues grew 1% year-over-year to $18.9 billion, supported by cost reductions and increased export volume [7]. - FedEx Freight revenues fell 4% year-over-year to $2.29 billion, impacted by lower fuel surcharges and increased costs [8]. Shareholder Returns - FedEx returned approximately $4.3 billion to shareholders in fiscal 2025, including $3 billion in share repurchases and $1.3 billion in dividends [12]. - The company plans to continue its robust share repurchase program and has announced a 5% dividend increase [15]. Future Outlook - For the first quarter of fiscal 2026, FedEx anticipates revenue growth of flat to 2% year-over-year, with diluted EPS expected between $2.90 and $3.50 [13]. - For the full year, FedEx expects permanent cost reductions of $1 billion from transformation programs and plans capital spending of $4.5 billion focused on efficiency improvements [14].

Core Insights - Hologic's consistent profitability has resulted in strong annual cash flow generation of approximately $1 billion, which supports a robust balance sheet and capital deployment strategy focused on tuck-in acquisitions and share repurchases [1][8] - Recent acquisitions, including Biotheranostics, Endomagnetics, and Gynesonics, are expected to enhance revenue growth and improve operating margins, as these businesses are growing faster than Hologic's legacy units [2][3][4] - Hologic maintains a strong financial position with $1.6 billion in cash and investments and a leverage ratio below 1X, allowing for continued investments in acquisitions and share buybacks [2][8] Acquisition Strategy - Hologic has allocated approximately $3.6 billion for share repurchases and $2 billion for mergers and acquisitions, with a focus on high-growth adjacent markets [1] - The integration of Biotheranostics is expected to benefit from increased lab testing volumes, while Endomagnetics is positioned to capture significant market opportunities in wireless localization [3] - Gynesonics' Sonata System is anticipated to strengthen Hologic's International Surgical business by providing a minimally invasive treatment option for uterine fibroids [4] Competitive Landscape - Hologic's rivals, such as Becton, Dickinson and Company and Thermo Fisher Scientific, are also engaging in share repurchases and acquisitions, with BDX reporting $625 million in free cash flow and TMO returning $2.1 billion to shareholders [5][6] - Hologic's stock has performed relatively well, rising 5.3% over the past three months, while the industry has seen an 8.6% decline [7] Financial Performance and Estimates - Hologic's forward two-year earnings multiple stands at 14.66X, indicating a favorable position relative to the industry [9] - Consensus estimates for Hologic's fiscal 2025 and 2026 earnings remain stable, with projected earnings of $4.19 for the current year and $4.50 for the next year [10][11]

Core Viewpoint - Jyske Bank has initiated a share repurchase program with a total value of up to DKK 2.25 billion, running from February 26, 2025, to January 30, 2026, in compliance with EU regulations [1]. Group 1: Share Repurchase Program Details - The share repurchase program is structured in accordance with the EU Commission Regulation No. 596/2014 and the Commission Delegated Regulation (EU) 2016/1052, collectively referred to as the "Safe Harbour Rules" [1]. - As of the latest announcement, Jyske Bank has accumulated a total of 1,101,985 treasury shares, which represents 1.79% of the share capital [2]. - The average purchase price of shares acquired under the program is DKK 547.25, with a total transaction value of DKK 603,060,688 [2]. Group 2: Transaction Summary - The program has seen various transactions, including: - On June 16, 2025, 15,000 shares were purchased at an average price of DKK 636.39, totaling DKK 9,545,919 [2]. - On June 17, 2025, 20,000 shares were acquired at DKK 628.09, amounting to DKK 12,561,798 [2]. - On June 18, 2025, 19,892 shares were bought at DKK 627.82, with a total value of DKK 12,488,633 [2]. - On June 19, 2025, 8,085 shares were purchased at DKK 622.52, totaling DKK 5,033,107 [2]. - On June 20, 2025, 13,479 shares were acquired at DKK 625.81, amounting to DKK 8,435,235 [2].

Core Insights - Nucor Corporation (NUE) anticipates earnings growth across all segments for Q2 2025, with the steel mills segment expected to see the most significant increase due to higher average selling prices [1][8] - The projected earnings per share (EPS) for Q2 2025 is between $2.55 and $2.65, a substantial rise from 67 cents in Q1 2025 [1][8] - The steel products segment is expected to benefit from stable pricing, increased volumes, and lower average costs per ton, contributing to sequential earnings growth [2] Financial Performance - Nucor repurchased approximately 1.8 million shares at an average price of $111.89 per share in Q2 2025, totaling around 4 million shares repurchased year-to-date at an average price of $123.75 [3] - The company has returned approximately $755 million to shareholders through share repurchases and dividends year-to-date [3] Stock Performance - NUE stock has experienced an 18.2% decline over the past year, which is less severe compared to the industry's 25.9% decline [5]

Key Takeaways CFG raised its share repurchase authorization by $1.2B, bringing the total to $1.5B. The move highlights management's confidence in CFG's financial strength and growth strategy. CFG also aims to grow via acquisitions, cost-cutting programs, and private banking expansion.Citizens Financial Group (CFG) is reinforcing its shareholder-focused strategy that highlights confidence in its long-term performance.Last week, the company announced an increase in its common share repurchase authorization ...

GMS (GMS) Q4 2025 Earnings Call June 18, 2025 08:30 AM ET Company Participants Carey Phelps - VP - IRJohn Turner - President & CEOScott Deakin - SVP & CFOMichael Dahl - Managing Director Conference Call Participants David Manthey - Senior Research AnalystMatthew Bouley - Senior Equity Research AnalystBrian Biros - Equity AnalystKurt Yinger - SVP & Research Analyst Operator Greetings, and welcome to GMS Inc. Fourth Quarter Fiscal Year twenty twenty five Earnings Conference Call. At this time, all participant ...

HOUSTON, June 17, 2025 /PRNewswire/ -- Third Coast Bancshares, Inc. (NASDAQ: TCBX) (the "Company," "Third Coast," "we," "us," or "our"), today announced that its Board of Directors has authorized a new share repurchase program (the "Repurchase Program"). This Repurchase Program allows the Company to buy up to $30 million of its common stock and will expire on May 22, 2026. Non-objection from the Federal Reserve Bank of Dallas related to the Repurchase Program was received June 16, 2025.Under the Repurchase ...

Core Viewpoint - Fifth Third Bancorp (FITB) has approved a new share repurchase authorization of up to 100 million shares, replacing the previous authorization of 11.8 million shares, providing flexibility for stock buybacks without a set expiration or price limit [1][2][7] Group 1: Share Repurchase Program - The new repurchase authorization allows for buybacks through open-market transactions or privately negotiated transactions, including Rule 10b5-1 programs [2] - The repurchase program can be modified, suspended, or discontinued based on market conditions and legal requirements [2] Group 2: Dividend Actions - In September 2024, FITB announced a 5.7% increase in its quarterly dividend to 37 cents per share, marking the fourth increase in the last five years [3] - The company has a payout ratio of 44%, and with a closing price of $38.32, the annualized dividend yield stands at 3.86% [3] Group 3: Financial Position - As of March 31, 2025, FITB had cash and due from banks totaling $17.9 billion, with total debt at $19.9 billion and short-term borrowings of $5.5 billion [4] - The common equity tier (CET) 1 ratio was reported at 10.45%, indicating room for enhancing capital distribution plans [4][5] Group 4: Market Performance - Over the past year, FITB shares have gained 6.2%, while the industry has seen a growth of 17.8% [6] - Currently, FITB holds a Zacks Rank of 3 (Hold) [8]